PHARMAMARK, the fifth edition of the Pharmaceutical Marketing Master’s Degree has just ended
The aim of the course, which Kedrion has supported from the first edition, is to train future sector managers
Kedrion Biopharma Recognized for innovation in Treating Rare Disease
Prestigious recognition presented for the first ever treatment for Plasminogen Deficiency
SIMTI 2022 Conference: Kedrion alongside the world of blood transfusion
A scientific symposium on Iron deficiency anemia and ferric derisomaltose
Kedrion and IPOPI: the journey continues at the 2022 IPIC
The Primary Immunodeficiencies International Congress took place during World PI Week
World Hemophilia Day: Kedrion’s commitment
Guaranteeing equitable access to treatment is the central theme of the 2022 edition
Kedrion alongside patients with Neuromuscular Disorders
The Company supports the day dedicated to this group of rare diseases for the fifth consecutive year
Kedrion-Pharmacosmos partnership for the treatment of Anemia in Italy
Exclusive agreement signed for the distribution of a novel iron-based therapy
Results of the “Words in Hemophilia: Towards Patient Engagement” study have been published
The project supported by Kedrion defines some of the key principles intended to improve patient envolvement
Kedrion and LFB sign industrial cooperation agreement
Scope is supplying Immunoglobulins to meet patient demand in France